en

PRODUCT DETAIL

Rybrevant 350 mg koncentrát na infúzny roztok

Code 9310D
MA number EU/1/21/1594/001
Product Form: con inf 1x7 ml/350 mg (liek.inj.skl.)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FX Other monoclonal antibodies and antibody drug conjugates
L01FX18 Amivantamab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 09.12.2021
Validity: 10.12.2024
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 26.09.2023
eu-flag.png sk-flag.png